From May 1, Pay More For Second Jab Of Covishield
Reported by Animesh Singh | Wednesday April 21, 2021COVID-19 vaccine: From May 1, 2021, a jab of Serum Institute of India's Covishield vaccine will cost Rs 600 in private hospitals.
India's New Unicorn Is EPharmacy
Saritha Rai, Bloomberg | Wednesday April 07, 2021API Holdings Pvt said it will use funds to expand its network and add more tele-consultations to link up customers with the 60,000 brick-and-mortar pharmacies and 4,000 doctors it already has on its books.
Cadila Seeks Nod To Repurpose Hepatitis C Drug For COVID-19 In India
Reuters | Monday April 05, 2021A single dose of the Hepatitis C drug when taken early could help COVID-19 patients recover faster and avoid complications seen in the advanced stages of the disease, Cadila said.
Indian Pharma Firms Go Local Seeking To End Reliance On China
Reuters | Tuesday February 23, 2021Indian Pharma Firms: Although India is known as the pharmacy of the world for its massive production capacities of both generic drugs and vaccines, China accounted for half of its API needs in 2019 from nearly nothing three decades ago
Dr Reddy's Starts Process For Emergency Use Authorisation Of Covid-19 Vaccine Sputnik V
Edited by Nirmalya Sen | Friday February 19, 2021Dr Reddy's will present the safety profile of phase two study and interim data of phase three study which is expected to completed by February 21
AstraZeneca Shares Up 4% On WHO's Emergency Use Approval Of Covid-19 Vaccine
Edited by Nirmalya Sen | Tuesday February 16, 2021WHO's move widens access to the relatively inexpensive shot in the developing world
Dr. Reddy's Laboratories Q3 Profit At Rs 20 Crore
Edited by Nirmalya Sen | Friday January 29, 2021Revenue for the third quarter came at Rs 4,930 crore, which was up 12 per cent year-over-year and 1 per cent quarter-over-quarter
Sun Pharma Q3 Profit Doubles To Rs 1,852.5 Crore
Edited by Nirmalya Sen | Friday January 29, 2021The pharma major reported a net profit of Rs 1,852.5 crore in Q3FY21
Novavax Claims Covid-19 Vaccine 89% Effective In UK Trial, Less In South Africa, Shares Jump
Edited by Nirmalya Sen | Friday January 29, 2021Serum Institute Of India has applied to conduct local trial for Novavax vaccine
Dr. Reddy's Ends Review Of Covid-19 Drug Avigan In Kuwait
Edited by Nirmalya Sen | Wednesday January 27, 2021Fujifilm, Dr. Reddy's and GRA had entered into a deal in July to sell Avigan globally excluding Japan, China and Russia
Moderna Believes Vaccine Will Work Against New Variants
Edited by Nirmalya Sen | Tuesday January 26, 2021Moderna Covid-19 Vaccine: The emergence of new variants in Britain, South Africa and Brazil has created some concern that mutations in the virus may make vaccines less effective
Will Receive Two Million AstraZeneca Doses By Friday From India: Brazil
Edited by Nirmalya Sen | Friday January 22, 2021The announcement comes amid delays in receiving the vaccine from India, the latest in a series of miscues surrounding the country's inoculations drive
India Will Start Commercial Vaccine Exports With Shipments to Morocco, Brazil
Edited by Nirmalya Sen | Friday January 22, 2021Serum Institute of India will also send the Covid-19 vaccine to South Africa and Saudi Arabia
South Africa To Pay $5.25 Per Dose For AstraZeneca Vaccine From India's SII
Edited by Nirmalya Sen | Thursday January 21, 2021South Africa is hosting clinical trials of the vaccine developed by AstraZeneca in partnership with Oxford University, raising questions about the higher price it will be paying
Serum Institute Awaits WHO Emergency Approval For AstraZeneca Shot Soon
Edited by Nirmalya Sen | Thursday January 14, 2021The World Health Organization (WHO) listed Pfizer and BioNTech's Covid-19 shot for emergency use on December 31 as it sought to accelerate vaccination in the developing world, which is badly lagging Western countries
